BridgeMD
New treatment option for Leukemia
Official title Comparison of Intralipid With SMOF Lipid Following HSCT
ClinicalTrials.gov ID: NCT06625372
What this study is testing
- What it's testing
- The goal of this clinical trial is to have a successful engraftment in after bone transplantation. Acute leukemia patient of both sexes aged 2 to 18 years, who are transplant candidates, participate in this study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 18
You may be able to join if
- Willingness to cooperate and complete the informed consent form by the legal guardian of the child;
- Age ≤ 18 years;
- Definitive diagnosis of acute leukemia and candidate for hematopoietic stem ● cell transplantation;
- Eligible for parenteral nutrition support;
- No contraindications for parenteral nutrition;
You likely can't join if
- Death of the child earlier than 5 days from the start of the intervention;
- Unwillingness to continue cooperation during study;
- Occurrence of side effects during the study;
- In case of sepsis, hypotension, shock, thrombosis, myocardial infarction, liver dysfunction, the patient will be excluded from the study.
See the full eligibility criteria
- Willingness to cooperate and complete the informed consent form by the legal guardian of the child;
- Age ≤ 18 years;
- Definitive diagnosis of acute leukemia and candidate for hematopoietic stem ● cell transplantation;
- Eligible for parenteral nutrition support;
- No contraindications for parenteral nutrition;
- No history of allergy to egg or soy protein;
- Absence of severe organ failure or impaired liver function test (bilirubin \> 2.5 mg/dL).
- Death of the child earlier than 5 days from the start of the intervention;
- Unwillingness to continue cooperation during study;
- Occurrence of side effects during the study;
- In case of sepsis, hypotension, shock, thrombosis, myocardial infarction, liver dysfunction, the patient will be excluded from the study.
The study team makes the final eligibility decision.
Where it's taking place
- Tehran, Iran
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tehran, Iran. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.